These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 36339006

  • 1. Comprehensive analysis of m5C-Related lncRNAs in the prognosis and immune landscape of hepatocellular carcinoma.
    Lu Q, Liu L, Wang S, Zhang Q, Li L.
    Front Genet; 2022; 13():990594. PubMed ID: 36339006
    [Abstract] [Full Text] [Related]

  • 2. Development and validation of a novel prognostic signature based on m6A/m5C/m1A-related genes in hepatocellular carcinoma.
    Xiao Y, Li J, Wu J.
    BMC Med Genomics; 2023 Jul 31; 16(1):177. PubMed ID: 37525171
    [Abstract] [Full Text] [Related]

  • 3. Analysis of m6A-related lncRNAs for prognostic and immunotherapeutic response in hepatocellular carcinoma.
    Wu X, Wang S, Wu X, Chen Q, Cheng J, Qi Z.
    J Cancer; 2024 Jul 31; 15(7):2045-2065. PubMed ID: 38434979
    [Abstract] [Full Text] [Related]

  • 4. Prognostic Risk Model and Tumor Immune Environment Modulation of m5C-Related LncRNAs in Pancreatic Ductal Adenocarcinoma.
    Yuan H, Liu J, Zhao L, Wu P, Chen G, Chen Q, Shen P, Yang T, Fan S, Xiao B, Jiang K.
    Front Immunol; 2021 Jul 31; 12():800268. PubMed ID: 34956238
    [Abstract] [Full Text] [Related]

  • 5. An integrative analysis revealing cuproptosis-related lncRNAs signature as a novel prognostic biomarker in hepatocellular carcinoma.
    Chen X, Sun M, Feng W, Chen J, Ji X, Xie M, Huang W, Chen X, Zhang B, Nie Y, Fan D, Wu K, Xia L.
    Front Genet; 2023 Jul 31; 14():1056000. PubMed ID: 36845390
    [Abstract] [Full Text] [Related]

  • 6. The Value of m5C-Related lncRNAs in the Prognostic Assessment and Immunotherapy of Stomach Adenocarcinoma.
    He C, Zhu X, Kong F, Zhang X, Chai X, Zou C, Zhao D.
    Biomed Res Int; 2022 Jul 31; 2022():2747799. PubMed ID: 35711526
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Construction of a m5C-related long non-coding RNA signature for the prognosis of hepatocellular carcinoma.
    Lu J, Wang H, Cao W, Chen D, He Z, Xu J.
    Hum Cell; 2023 Mar 31; 36(2):712-724. PubMed ID: 36520346
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cuproptosis-related long non-coding RNAs model that effectively predicts prognosis in hepatocellular carcinoma.
    Huang EM, Ma N, Ma T, Zhou JY, Yang WS, Liu CX, Hou ZH, Chen S, Zong Z, Zeng B, Li YR, Zhou TC.
    World J Gastrointest Oncol; 2022 Oct 15; 14(10):1981-2003. PubMed ID: 36310708
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The prognostic value and immune landscaps of m6A/m5C-related lncRNAs signature in the low grade glioma.
    Li R, Chen H, Li C, Qi Y, Zhao K, Wang J, You C, Huang H.
    BMC Bioinformatics; 2023 Jul 04; 24(1):274. PubMed ID: 37403043
    [Abstract] [Full Text] [Related]

  • 15. The m6A/m5C/m1A Regulated Gene Signature Predicts the Prognosis and Correlates With the Immune Status of Hepatocellular Carcinoma.
    Li D, Li K, Zhang W, Yang KW, Mu DA, Jiang GJ, Shi RS, Ke D.
    Front Immunol; 2022 Jul 04; 13():918140. PubMed ID: 35833147
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
    Wang Y, Zhu GQ, Tian D, Zhou CW, Li N, Feng Y, Zeng MS.
    BMC Cancer; 2022 Mar 24; 22(1):316. PubMed ID: 35331183
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The m6A/m5C/m1A regulator genes signature reveals the prognosis and is related with immune microenvironment for hepatocellular carcinoma.
    Liu T, Sun L, Li ZZ, Yang K, Chen JM, Han XY, Qi LM, Zhou XG, Wang P.
    BMC Gastroenterol; 2023 May 11; 23(1):147. PubMed ID: 37170222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.